Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What is the recommended dosage for bosentan in liver impairment?

See the DrugPatentWatch profile for bosentan

Standard Bosentan Dosage

Bosentan (Tracleer) treats pulmonary arterial hypertension (PAH). The usual starting dose for adults is 62.5 mg twice daily for 4 weeks, then 125 mg or 250 mg twice daily based on tolerability and weight. It's taken orally with or without food.[1]

Dosage in Mild Liver Impairment (Child-Pugh A)

No dose adjustment needed. Use standard dosing: start at 62.5 mg twice daily, titrate to 125 mg twice daily.[1][2]

Dosage in Moderate Liver Impairment (Child-Pugh B)

Avoid use. Bosentan is contraindicated due to risk of liver injury and elevated transaminases.[1][2]

Dosage in Severe Liver Impairment (Child-Pugh C)

Avoid use. Contraindicated; higher risk of hepatotoxicity.[1][2]

Monitoring and Adjustments

Check liver enzymes (ALT/AST) before starting, monthly for first 3 months, then every 3 months. Discontinue if ALT/AST >8x upper limit of normal or >5x with symptoms/bilirubin >2x upper limit. Reduce dose by 50% if mild elevation (3-5x upper limit).[1]

Why Liver Impairment Matters

Bosentan is metabolized by CYP3A4 in the liver, with biliary excretion. Impairment raises drug levels, increasing hepatotoxicity risk. Label warns against use in moderate/severe cases.[1][2]

[1]: Tracleer Prescribing Information (FDA)
[2]: DrugPatentWatch.com - Bosentan



Other Questions About Bosentan :

Can bosentan cause serious side effects leading to withdrawal? How sudden should bosentan discontinuation be with serious side effects? Can liver damage require bosentan discontinuation?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy